173 related articles for article (PubMed ID: 36551233)
1. Alteration of Cellular Energy Metabolism through LPAR2-Axin2 Axis in Gastric Cancer.
Ara H; Subedi U; Sharma P; Bhattarai S; Sharma S; Manikandan S; Yu X; Bhuiyan MS; Sun H; Miriyala S; Panchatcharam M
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551233
[TBL] [Abstract][Full Text] [Related]
2. LPA
Pei J; Cai L; Wang F; Xu C; Pei S; Guo H; Sun X; Chun J; Cong X; Zhu W; Zheng Z; Chen X
Circ Res; 2022 Aug; 131(5):388-403. PubMed ID: 35920162
[TBL] [Abstract][Full Text] [Related]
3. LPAR2-mediated action promotes human renal cell carcinoma via MAPK/NF-κB signaling to regulate cytokine network.
Wang Y; Qi Z; Li Z; Bai S; Damirin A
J Cancer Res Clin Oncol; 2023 May; 149(5):2041-2055. PubMed ID: 35857125
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway.
Yang M; Zhong WW; Srivastava N; Slavin A; Yang J; Hoey T; An S
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6027-32. PubMed ID: 15837931
[TBL] [Abstract][Full Text] [Related]
5. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
6. Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2.
Yang D; Yang W; Zhang Q; Hu Y; Bao L; Damirin A
Oncol Lett; 2013 Mar; 5(3):1048-1052. PubMed ID: 23426604
[TBL] [Abstract][Full Text] [Related]
7. Lemur tyrosine kinase 2 silencing inhibits the proliferation of gastric cancer cells by regulating GSK-3β phosphorylation and β-catenin nuclear translocation.
Han X; Wang DZ; Yuan M; Bai WJ
Bioengineered; 2022 Mar; 13(3):6231-6243. PubMed ID: 34719320
[TBL] [Abstract][Full Text] [Related]
8. PTEN Gene Induces Cell Invasion and Migration via Regulating AKT/GSK-3β/β-Catenin Signaling Pathway in Human Gastric Cancer.
Ma J; Guo X; Zhang J; Wu D; Hu X; Li J; Lan Q; Liu Y; Dong W
Dig Dis Sci; 2017 Dec; 62(12):3415-3425. PubMed ID: 29030742
[TBL] [Abstract][Full Text] [Related]
9. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
Ryu JM; Han HJ
Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid activates β-catenin/T cell factor signaling, which contributes to the suppression of apoptosis in H19-7 cells.
Sun Y; Kim NH; Ji L; Kim SH; Lee J; Rhee HJ
Mol Med Rep; 2013 Dec; 8(6):1729-33. PubMed ID: 24145616
[TBL] [Abstract][Full Text] [Related]
11. The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.
Lin S; Lee SJ; Shim H; Chun J; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1128-38. PubMed ID: 20724530
[TBL] [Abstract][Full Text] [Related]
12. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer.
Zheng CH; Wang JB; Lin MQ; Zhang PY; Liu LC; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Xie JW; Li P; Huang CM
J Exp Clin Cancer Res; 2018 Mar; 37(1):59. PubMed ID: 29540196
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway.
Chen L; Xu M; Zhong W; Hu Y; Wang G
Exp Cell Res; 2021 Feb; 399(1):112448. PubMed ID: 33347858
[TBL] [Abstract][Full Text] [Related]
14. CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway.
Pan J; Fan Z; Wang Z; Dai Q; Xiang Z; Yuan F; Yan M; Zhu Z; Liu B; Li C
J Exp Clin Cancer Res; 2019 Feb; 38(1):52. PubMed ID: 30717785
[TBL] [Abstract][Full Text] [Related]
15. Krüppel-like factor 5 incorporates into the β-catenin/TCF complex in response to LPA in colon cancer cells.
Guo L; He P; No YR; Yun CC
Cell Signal; 2015 May; 27(5):961-8. PubMed ID: 25683913
[TBL] [Abstract][Full Text] [Related]
16. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
Li HL; Liang S; Cui JH; Han GY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):127-134. PubMed ID: 29364479
[TBL] [Abstract][Full Text] [Related]
17. CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signaling.
Wang JB; Wang ZW; Li Y; Huang CQ; Zheng CH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Lin Y; Huang CM
Cancer Lett; 2017 Jan; 385():188-197. PubMed ID: 27793695
[TBL] [Abstract][Full Text] [Related]
18. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
Hidaka Y; Mitomi H; Saito T; Takahashi M; Lee SY; Matsumoto K; Yao T; Watanabe S
Hum Pathol; 2013 Nov; 44(11):2438-48. PubMed ID: 24011952
[TBL] [Abstract][Full Text] [Related]
19. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
Yu X; Zhang Y; Chen H
BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
[TBL] [Abstract][Full Text] [Related]
20. Beta-catenin, cancer, and G proteins: not just for frizzleds anymore.
Malbon CC
Sci STKE; 2005 Jul; 2005(292):pe35. PubMed ID: 16014605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
